FDA DrugClass IINotable

FDA Recall: Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106

Date: 2026-03-11
Brand: Harbin Jixianglong Biotech Co., Ltd.
Category: Drug
FDA Class: Class II

Description

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Hazard

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Remedy

N/A

View original recall →
Share:

Related Recalls

2026-05-06 · FDA_DRUG
FDA Recall: Similasan, iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in France,
Thea Pharma, Inc.
2026-05-06 · FDA_DRUG
FDA Recall: Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx O
American Regent, Inc.
2026-05-06 · FDA_DRUG
FDA Recall: GenTeal Tears, Lubricant Eye Gel, Sterile, 10g (0.34 Fl oz), Distributed by: Alcon Laboratories, Inc
Alcon Research LLC
2026-05-06 · FDA_DRUG
FDA Recall: fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg p
Wells Pharma of Houston LLC